These are top 10 stocks traded on the Robinhood UK platform in July
On Wednesday, BTIG analyst Gregory Lewis (JO:LEWJ) maintained a Neutral rating on Oklo Inc. (NYSE: OKLO) following their first-quarter 2025 earnings report. The company reported an operating loss of approximately $18 million. Currently trading at $32.03, the stock has shown remarkable momentum with an 18.1% gain in the past week, though InvestingPro analysis suggests the stock is trading above its Fair Value. Analyst price targets range from $30 to $58, reflecting mixed sentiment about the company’s prospects. Despite the loss, Oklo is moving forward with the development of its first Aurora power plant at the Idaho National Laboratory (INL). Earlier today, Oklo announced the completion of drilling for site characterization work, a step towards the integration of findings into the Combined License application (COLA) with the Nuclear Regulatory Commission (NRC), which is required to build and operate each Aurora plant. With a market capitalization of $4.45 billion and a strong liquidity position (current ratio of 36.23), the company appears well-positioned to fund its development plans. For deeper insights into Oklo’s financial health and growth prospects, InvestingPro subscribers can access the comprehensive Pro Research Report, which includes detailed analysis of the company’s fundamentals and growth trajectory.
Oklo’s management is planning to submit its COLA later this year, leveraging the ADVANCE Act, which is set to take effect in October 2025 and is expected to reduce licensing costs by about 55%. The company has already commenced the first phase of pre-application assessment with the NRC, which is anticipated to accelerate the application process. The startup of the INL plant is projected for late 2027 or early 2028.
The company holds a design certification for a ~15MW plant, which is part of the COLA process. This certification is expected to shorten the timeline for future plants of similar specifications by 1-2 years compared to the conventional regulatory process. Oklo’s continued progress on its initial plant comes as it prepares for NRC approval later in the year. The firm’s regulatory approval is seen as a crucial factor in securing approximately 14 gigawatts of existing letters of intent (LOIs). InvestingPro data shows the company maintains a ’FAIR’ overall financial health score, with particularly strong momentum metrics, suggesting solid execution of its development strategy.
In other recent news, Oklo Inc. reported a slight beat in its Q1 2025 earnings per share (EPS), posting an actual EPS of -$0.07 compared to the forecast of -$0.08. Despite this positive surprise, the company experienced an operating loss of $17.9 million, with significant investments in product development and innovation. Oklo is advancing its Aurora Powerhouse, a 75-megawatt advanced nuclear reactor, and expanding its customer pipeline, which exceeds 14 gigawatts. Additionally, Oklo is making progress in licensing a commercial fuel fabrication site, with the first reactor deployment expected in the late 2027 to early 2028 timeframe. Citi analyst Vikram Bagri maintained a Neutral rating on Oklo shares, setting a price target of $30.00, following Oklo’s initiation of Phase 1 of the pre-application readiness assessment. Oklo’s Atomic Alchemy™ demonstration lab is on track to begin generating revenue from early to mid-2026, with a larger facility anticipated to follow in 2028. The departure of Sam Altman from Oklo’s Board is viewed as a potential opportunity to enhance discussions with data centers and explore a relationship with OpenAI. These developments are part of Oklo’s broader strategy to deploy its initial reactor and expand its isotope business.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.